Wednesday, 16 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14398
Articles
Company
Deals
Simcere Pharma to Spin Off Zaiming Unit for Hong Kong IPO
January 12, 2026
Company
Deals
Nona Biosciences Partners with Link Cell on CAR-T Discovery Using HCAb Platform
January 12, 2026
Company
Drug
Hengrui’s Quadruple Prostate Cancer Combo Wins NMPA IND for Phase 2 Study
January 12, 2026
Company
Drug
Shanghai Pharma Receives NMPA Approval for Myasthenia Gravis Oral Solution
January 12, 2026
Company
Drug
FDA Announces Flexible CMC Pathway for Cell and Gene Therapies to Accelerate Development
January 12, 2026
Company
Drug
Huadong Medicine’s DR10624 Wins Breakthrough Designation for Severe Hypertriglyceridemia
January 12, 2026
Medical Device
Dongcheng Pharma’s PSMA PET Agent [18F] Spiritide NDA Accepted by NMPA
January 12, 2026
Company
Novartis to Build $23 Billion RLT Facility in Florida, Expanding Cancer Therapy Capacity
January 12, 2026
Company
Deals
Pierre Fabre Partners with Iktos on AI-Driven Oncology Drug Discovery
January 12, 2026
Policy / Regulatory
NHSA Launches Personal Healthcare Insurance Cloud Pilot Program
January 12, 2026
Policy / Regulatory
China Expands Medical Insurance Personal Account Pooling Nationwide
January 12, 2026
Company
Deals
Haisco Licenses COPD Drug HSK39004 to AirNexis for $1.06 Billion
January 12, 2026
1
2
…
188
189
190
191
192
…
1,199
1,200
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?